Representatives Across the U.S. Fight for Lower Drug Costs - Except Mitch McConnell
Will you share this article to help us lower prescription drug costs?
Across the U.S., Americans are unable to afford their prescriptions. Extremely high costs have forced Americans to choose between their next meal and life-saving prescriptions.
Within 2019 alone, manufacturers increased prices on 457 brand name drugs by 5.1%. In December of 2019, the House passed an ambitious bill to lower prescription drug costs. This bill would allow the U.S. government to directly negotiate drug prices for Medicare recipients, saving more than $450 billion in spending reductions for the program within 10 years.
The House isn't alone in this effort to lower drug costs, as Representatives across the U.S. have put forward their plans for lowering drug costs on a state level.
- Oklahoma Sen. Paul Scott recently filed a bill that would lower prescription drug prices for employees.
- New Jersey Sen. Troy Singleton introduced a bill that calls for a drug affordability board and another bill that requires the Department of Treasury to enter bulk purchasing agreement for prescriptions for state employees and Medicaid recipients.
- Maryland has just created a new board that will investigate how to keep drug costs low in the state.
Dozens of other bills have been put forward. Clearly, the need for lower drug costs has been heard by everyone except Mitch McConnell. The Lower Drug Costs Now Act sits untouched on Mitch McConnell's desk, along with hundreds of other bi-partisan passed bills.
When will Mitch step up and help the very Americans that elected him? People are drowning in the costs of their necessary prescriptions and Mitch McConnell continues to deny them any help.
We need your help to #LowerDrugCosts now. Will you share this article on Twitter or Facebook?
To see more content like this, help support Future Majority here.
Your Daily Round Up for February 28thGood afternoon. Here are the latest news and updates that our team at Future Majority is tracking. Another Saturday, another
#TrumpSlump Stresses Global MarketsWall Street Journal Reports: U.S. Stocks Fall on Fresh Trade Tensions U.S. stocks fall as a result of Trump's tweet saying he Infrastructure
Memo - How we got here: COVID-19 in the U.S.It’s hard to describe how events have turned in the past several weeks in the United States. What once seemed like a far-off Healthcare